Family Dollar Hydrocortisone and Cortizone Creams Recalled for Storage Deviation
Family Dollar Stores is recalling hydrocortisone cream (1 oz, SKU 910321) and Cortizone 10 Creme (0.5 oz, SKU 910167) distributed April 30 through June 10, 2022, due to improper storage temperature conditions.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II drug recall due to CGMP deviation involving storage temperature violations. No reported illnesses or injuries, but improper storage of a topical corticosteroid represents a risk-of-harm product where product efficacy or integrity may be compromised.
Plain-English summary
Family Dollar Stores, Llc. is recalling FS Hydrocortisone Cream 1 oz (SKU 910321) and Cortizone 10 Creme 0.5 oz (SKU 910167) distributed to select Family Dollar Stores locations from April 30, 2022 through June 10, 2022. The products are being recalled due to a Current Good Manufacturing Practice (CGMP) deviation involving storage temperature violations.
The products affected by this recall were stored outside appropriate temperature conditions during distribution. Improper storage of topical corticosteroids may affect product quality, safety, or efficacy.
Consumers who purchased these products during the distribution period from affected Family Dollar Stores should contact Family Dollar Stores for information about the recall and disposition of the products.
The recalled product
- Product
- FS HYDROCORTISONE CREAM 1 OZ SKU 910321 CORTIZONE 10 CREME 0.5 OZ SKU 910167 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical corticosteroid
- Hazard
- storage-temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 910321
- 910167
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27